Search results
Moderna’s Covid-19 vaccine meets primary efficacy endpoint in Phase III trial
Clinical Trials Arena via Yahoo Finance· 12 hours agoModerna has announced that its Phase III clinical trial of the investigational next-generation...
Pharma Stock Roundup: FDA Panel Endorses LLY's Donanemab, PFE's DMD Therapy Study Fails
Zacks via Yahoo Finance· 7 hours agoThis week, an FDA advisory committee unanimously recommended approval of Eli Lilly’s LLY Alzheimer's...
Aldeyra Therapeutics concludes subject enrolment in dry eye disease trial
Clinical Trials Arena via Yahoo Finance· 10 hours agoAldeyra Therapeutics has concluded the subject enrolment in its Phase III clinical trial of topical...
Pfizer’s Phase III DMD gene therapy trial misses primary endpoint
Clinical Trials Arena via Yahoo Finance· 2 days agoPfizer has reported that its Phase III CIFFREO clinical trial of investigational mini-dystrophin...
Takeda signs option agreement with Ascentage for CML drug
Pharmaceutical Technology via Yahoo Finance· 3 hours agoUnder the terms of the agreement, Ascentage will continue to be solely responsible for all clinical...
Moderna announces positive Phase III data for Covid-19/Influenza mRNA vaccine
Clinical Trials Arena via Yahoo Finance· 2 days agoModerna has announced positive Phase III data for its Covid-19/influenza combination vaccine,...
Friday Dance Music Guide: The Week’s Best New Tracks From Tokimonsta, SG Lewis & Tove Lo, Sofi...
Billboard via Yahoo News· 2 hours agoA singalong anthem about a relationship in its downward trajectory phase, the song is built around...
Pfizer (PFE) Phase III DMD Gene Therapy Study Misses Goal
Zacks· 2 days agoFree Report) announced that a phase III study on its mini-dystrophin gene therapy fordadistrogene movaparvovec for treating Duchenne muscular dystrophy ...
UBS keeps G-III Apparel stock at Neutral, awaits stronger growth signs By Investing.com
Investing.com· 1 day agoThe firm's stance remains cautious due to G-III Apparel's significant dependence on Department...
Viridian Therapeutics to begin Phase III trials of thyroid eye disease treatment
Clinical Trials Arena via Yahoo Finance· 2 days agoUS-based biotechnology company Viridian Therapeutics has announced plans to begin two Phase III...